For research use only.
Sermorelin
Sermorelin is a lab-made copy of the first 29 amino acids of natural growth hormone-releasing hormone (GHRH), the shortest synthetic piece that still carries GHRH’s full biological activity on growth hormone release.[1][2]
Pathway: GHRH. It’s a lab-made copy of the first 29 amino acids of natural GHRH, the brain’s "go" signal for growth hormone.[1][3][4]
Origin: Studied as GHRH(1-29) in children and adults, then FDA approved as Geref (sermorelin acetate) for diagnosing and treating growth hormone issues; those brand products were later discontinued.[1][5]
Research areas
Human studies and the former FDA-approved labels point to several research and labeled uses.
- Diagnosing whether the pituitary can release growth hormone, a former labeled use for one Geref product[5]
- Treating idiopathic growth hormone deficiency with growth failure in children, a former labeled use for another Geref product[1][5]
- Raising growth hormone and IGF-I signals in older adults in research settings[3][4]
Evidence level
Level 4 of 4: Large human trialsSermorelin acetate was FDA approved as Geref for labeled diagnostic and pediatric growth-hormone uses, based on clinical evidence in children and related human studies.[1][5]
Why so few human trials?Cautions
Studies and regulators point to several reasons for care.
- The brand-name Geref products were discontinued by the sponsor and FDA withdrew those NDAs; FDA later determined the withdrawal was not for reasons of safety or effectiveness[5]
- Research materials are not the discontinued Geref medicines[5]
- A normal growth hormone response to sermorelin does not by itself rule out growth hormone deficiency caused higher up in the brain, according to a clinical review[1]
Sermorelin acetate was FDA approved as Geref for labeled uses; those brand products were discontinued, and FDA determined the discontinuation was not for safety or effectiveness reasons.[5]
Sermorelin goes by several names.
Storage basics General
These general basics apply to most freeze-dried research peptides.
Sources and studies
These studies and official pages are the research behind this profile.
- 1Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiencyPrakash A, Goa KL (1999) · BioDrugs
- 2Treatment of growth-hormone deficiency with growth-hormone-releasing hormoneRoss RJ, et al. (1987) · The Lancet
- 3Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old menCorpas E, et al. (1992) · The Journal of Clinical Endocrinology & Metabolism
- 4Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly menVittone J, et al. (1997) · Metabolism
- 5Determination That GEREF (Sermorelin Acetate) Injection… Were Not Withdrawn From Sale for Reasons of Safety or EffectivenessU.S. Food and Drug Administration (2013) · Federal Register
- 6Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analogJetté L, et al. (2005) · Endocrinology